You are being redirected to the story the piece of content is found in so you can read it in context. Please click the following link if you are not automatically redirected within a couple seconds:
Drug giant GlaxoSmithKline pledges cheap medicine for world's poor
Author: Sarah Boseley, Guardian [UK], Published on: 13 February 2009
The world's second biggest pharmaceutical company is to radically shift its attitude to providing cheap drugs to millions of people in the developing world. In a major change of strategy, the new head of GlaxoSmithKline, Andrew Witty, has [said] he will slash prices on all medicines in the poorest countries, give back profits to be spent on hospitals and clinics and – most ground-breaking of all – share knowledge about potential drugs that are currently protected by patents...He challenges other pharmaceutical giants to follow his lead...Campaigners gave a cautious welcome to GSK's strategy. But Oxfam and Médecins Sans Frontières both said the company should go further and include HIV drugs in the patent pool...
Related companies: GlaxoSmithKline